Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab

Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab

Key Clinical Message A severe and persistent migrainous headache in a patient with primary Sjøgren's syndrome unresponsive to treatment with immunosuppressive drugs, triptans, opioids, and NSAIDs, responded successfully to intrathecal B‐cell depletion with rituximab. We hypothesize that brain‐r...

Full description

Bibliographic Details
Main Authors: Anne Bolette Tjensvoll, Maria Boge Lauvsnes, Katrine Brekke Norheim, Roald Omdal
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Clinical Case Reports
Subjects:
B cell depletion in CSF
Headache
Primary Sjögren’s syndrome
Systemic lupus erythematosus
Online Access:https://doi.org/10.1002/ccr3.1987

Similar Items

Similar Items